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Dr. Alfred T. Lane (Stanford University) orga-
nized the sixteenth annual meeting of the Society
for Pediatric Dermatology, held in Wiliiamsburg,
Virgitiia. The seventh annual Sidney Hurwitz Lec-
ture was delivered by Dr. Rona M. MacKie (Uni-
versity of Glasgow) on "Melanoma: Risk Factors in
Dysplastic Nevus Syndrome." President Anne
Lucky (Cincinnati, Ohio) welcomed the society
members to Wiliiamsburg and introduced the first
speaker.
COLONIAL MEDICINE
Dr. Tor A. Shwayder (Henry Ford Hospital) pre-
sented a delightful and professional "Character In-
terpreter Portrayal of Iseiac Shwayder, Medical
Doctor (circa 1799)." Complete in eighteenth-
century costume, including three-cornered hat and
silk hose. Dr. Shwayder discussed the art and sci-
ence of medicine as it evolved in colonial Willisuns-
burg. However, he became distracted from his lec-
ture by the newspaper account he received, dated
December 17, 1799, telling of General George
Washington's death. We learn the story of General
Washington's rapid demise, probably from bacterial
infection, hastened by the medical treatments of the
day, including frequent and copious blood letting.
There was a current saying, "more people died an-
nually from lancets than from swords."
MELANOMA: RISK FACTORS AND
DYSPLASTIC NEVUS SYNDROME
Dr. Rona MacKie first discussed risk factors in mel-
anoma, citing several large case control studies car-
ried out in western Canada, Scotland, Scandinavia,
and Germany. The frequency of melanoma has dou-
bled each decade in Scandinavia, the United King-
dom, and Germany. The frequency increases with
high altitudes, low latitudes, pale skin, outdoor rec-
reation, and total number of banal, nondysplastic
nevi. Other risk factors are the tendency to freckle,
a history of severe sunburn, three or more clinically




ated with acquisition of large numbers of banal nevi
include one or more years of childhood spent in the
tropics, Mediterranean holidays when less than 5
years old, light skin that bums rather than tatis, se-
vere sunburn in childhood, and freckling. The
working hypothesis is that these early childhood
events act as initiating factors that may induce be-
nign meianocytic lesions. Later, further sun expo-
sure may lead to both promotion and progression,
with the development of melanoma.
An additional risk factor for the development of
melanoma is the presence of clinically atypical and
pathologically dysplastic nevi (DN). There is much
confusion regarding the use of the term "dysplastic
nevus" because experts do not agree on pathologic
criteria. Elder's clinical criteria are size greater than
5 mm, irregular outline, "fried egg" profile, varie-
gated pigmentation, and erythema. His pathologic
criteria are basilar meianocytic hyperplasia, cyto-
logic meianocytic atypia, fusion of meianocytic
nests, lymphocytic infiltrate, lamellar or concentric
fibroplasia, and rete ridge elongation.
The four categories of DN according to the NIH
Consensus Conference are (A) sporadic; (B) famil-
ial nevi with no melanoma; (C) sporadic personal
melanoma (not in the fEunily, patient only); (D,) fa-
milial nevi with personal melanoma and one family
member with melanoma, and (D2) familial nevi with
personal melanoma and two family members with
melanoma. The increased risk of melanoma de-
pending on the type of dysplastic nevus is as fol-
lows: type A, 4-fold increase; type B, 7-fold in-
crease; type C, 80-fold increase; type D, 108-fold
increase. It was noted that melanoma was ex-
tremely rare prepubertally, but in the few patients
in whom it has occurred, 50% developed in giant
meianocytic nevi.
In Dr. MacKie's current study of melanomas in
individtials under age 30 years, a significant associ-
ation exists between the presence of a nevus since
early life and the development of melanoma at that
site. This suggests that a portion of congenital or
early-onset small nevi have the potential for malig-
nant change. Continuing studies wiU attempt to es-
tabhsh the rate at which this occurs and guidehnes
for the management of small congenital nevi. Be-
cause these melanomas do not seem to develop
prior to puberty—approximately 1 chance in 100 ex-
ists that a smdl congenital nevus will become ma-
lignant by 13 years of age—it is reasonable to offer
excision of small congenital nevi at puberty. Of 95
patients who developed melanoma at age 30 or less,
44% had evidence of a preexisting, small congenital
nevus at the site. The melanomas that developed on
these nevi tended to be thick. Dr. MacKie recom-
mended a photographic record of dysptastic nevi in
children, and removing those that developed char-
acteristics suggestive of melanoma.
HERPES SIMPLEX INFECTIONS IN CHILDREN
Dr. J. Clark Huff (University of Colorado) dis-
cussed the four types of herpes simplex virus (HSV)
infection in children: initial (primary) infection; re-
activation (recurrent) infection; infection in the im-
munocompromised host; and herpes-associated er-
ythema multiforme (EM).
Initial or primary HSV infection is most com-
motily subclinical or unrecognized. Older literature
stated that 95% of the United States population was
seropositive, but current studies revised this figure
to 52% to 65%.
Neonatal HSV infection occurs in about 1 in 14(X)
live births—that is, 1500 to 2200 affected infants per
year in the United States. Seventy percent of the
cases are due to HSV-2. Risk factors for neonatal
HSV infection are thought to include asymptomatic
shedding from the maternal genital tract, especially
the cervix, at the time of delivery; recently acquired
subclinical first episode infection; reactivation
herpes with shedding (although risk is only about
3% in these infants); and the absence of maternal
antibodies to HSV-2. Neonatal HSV localized to
the skin, eye, or mucous membrane is associated
with no mortality. When encephalitis is present,
mortality is 15%, and of those who survive, 64%
have severe sequelae, usually mental retardation. If
the infection is disseminated but no encephalitis is
present, mortality is 57% and morbidity at one year
is 41%. Treatment is acyclovir 30 mg/kg/day intra-
venously for 10 days.
An HSV infection in the immunocompromised
host is often extremely severe. Treatment is intra-
venous acyclovir 30 mg/kg/day for 10 days.
The HSV-associated EM is usually a minor form
of EM, and follows recurrent HSV by 3 to 21 days.
The polymerase chain reaction (PCR) has been used
to identify herpes virus DNA in skin lesions of EM.
In HSV-associated EM, 100% of lesions had HSV
DNA. Fifty percent of patients with idiopathic EM
had evidence of HSV DNA in lesions. Prophylaxis
includes oral acyciovir 400 to 800 mg/day.
The diagnosis of HSV can be made on culture,
which is usually positive in one to two days. A new
technique involves culturing for 24 to 48 hours and
then fluorescent antibody staining. Tzanck prepara-
tion is reliable in new vesicles. Immunocytology,
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enzyme-linked immunosorbent assay of blister
fluid, and spin amplification techniques are avail-
able at some institutions.
NUTRITIONAL DEFICIENCY
Dr. Moise L. Levy (Baylor College) discussed the
cutaneous signs of four types of nutritional defi-
ciency: protein-energy malnutrition, vitamin defi-
ciencies, essential fatty acid deficiency, and trace
element deficiency. Protein-energy malnutrition is
the most common worldwide and is recognized clin-
ically as kwashiorkor or marasmus. Either can fol-
low poor dietary intake, maiabsorption, or catabolic
state.
The skin in kwashiorkor shows hypopigmenta-
tion and diffuse pitting edema. Waxy elevated
plaques ("enamel paint") or erosions ("flaky
paint") are often seen. In marasmus the skin is dry,
wrinkled, and loose, often producing "monkey
facies." The hair is reddish and thin in kwashior-
kor, and alternating periods of adequate and inade-
quate nutrition are reflected in alternate bands of
color in the hair, the so-called flag sign. In maras-
mus the hair is also thin and slow growing, and
lanugo hair may be seen.
Deficiencies of vitamins A, B, and C also pro-
duce skin signs. Vitamin A deficiency produces foi-
hcular papules, so-called phrynoderma. Xerosis is
prominent, as are ophthalmologic abnormalities in-
cluding Bitot spots and keratomalacia, with iris pro-
lapse in severe cases.
Vitamin C deficiency produces scurvy, and most
cases are due to inadequate intake. Skin manifesta-
tions include corkscrew hairs (secondary to de-
crease in disuUide bonds in the affected hairs),
perifoUictilar hemorrhage, gingival edema and hem-
orrhage, weakness, depression, diarrhea, and ane-
mia.
Essential fatty acid deficiency occurs in prema-
ture itifants with inadequate adipose stores. Unsat-
urated fatty acids that cannot be synthesized by hu-
mans are necessary for membrane structure and the
production of eicosanoids. Linoleic acid is the pri-
mary nutrient for treating or preventing this defi-
ciency. Clinically, alopecia, xerosis, and scaling are
present. The infants have retarded growth and show
an increased susceptibility to infection.
Trace element deficiency is correctable when the
deficiency is in iron, copper, zinc, chromium, man-
ganese, or iodine. Zinc deficiency is caused by in-
adequate intake, including breast milk deficient in
zinc, increased excretion, or a genetic factor. Clin-
ically, acral and pehorficial dermatitis occur. Paro-
nychia, angular stomatitis, glossitis, and alopecia
often are present. Impaired wound healing, growth
retardation, marked irritability, diarrhea, and im-
mune abnormalities may be seen.
COAGULATION DISORDERS
Dr. Hazel Vemon (Medical College of Virginia) dis-
cussed three coagulation disorders with manifesta-
tions in the skin: protein C deficiency, purpura ful-
minans, and the Kasabach-Merritt syndrome.
Homozygous protein C deficiency is extremely
rare, with only 17 confirmed cases in the United
States and Europe. Protein C activity is usually less
than 1%, with protein C antigen ranging from less
than 1% to 30%. The three major clinical findings in
these newboms are the onset of ecchymoses and
necrotic lesions within 2 to 12 hours of birth, central
nervous system thromboses, and blindness. Hema-
tologic studies show a picture of disseminated intra-
vascular coagulation with decreased platelets and
fibrinogens, elevated fibrin split products, and pro-
longed activated partial thromboplastin and pro-
thrombin times. PVotein C levels are low or absent.
Histologic examination of a skin biopsy specimen
reveals extensive thrombosis with fibrinoid necro-
sis of vessel walls and hemorrhage into subcutane-
ous fat, but without vasculitis. Treatment includes
fresh-frozen plasma given daily, or protein C and S
concentrates. Warfarin may also be given.
Purpura fulminans is characterized by the sudden
onset of hemorrhagic necrosis of the skin and dis-
seminated intravascular coagulation, as well as
widespread cutaneous thrombosis. It usually arises
in the setting of an overwhelming infection due to
Haemophilus influenzae, or meningococcal, strep-
tococcal, or staphylococcal infection. Tumor necro-
sis factor is thought to act as a procoagulant, to-
gether with bacterial endotoxin. Treatment includes
eradicating the infectious cause and supporting the
child with platelets and fresh-frozen plasma. Hepa-
rin, dextran, steroids, plasmapheresis, and uroki-
nase have been used in the treatment of purpura ful-
minans.
Kasabach-Merritt syndrome is a localized con-
sumption coagulopathy occurring within a very
large hemangioma, most commonly on the extrem-
ity. The median age of onset of the syndrome is 5
weeks (range birth-73 yrs). The mortality rate is
21%. Usually the size of the hemangioma increases
suddenly, with the development of petechiae or ec-
chymoses elsewhere, and gastrointestinal bleeding.
Laboratory studies show a picture of disseminated
intravascular coagulation. Current recommenda-
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tions for therapy include high-dose prednisone (2-4
mg/kg/day), expecting improvement within several
days. Surgery can be attempted if the lesion is ac-
cessible and relatively small. Epsilon-aminocaproic
acid (Amicar) can be used to allow the hemangioma
to clot and scar, with a response seen after two
weeks. Finally, intermittent pneumatic compres-
sion can be tried if the hemangioma is in an appro-
priate location. It is used 24 hours per day until in-
volution begins and then is used nightly.
CLINICOPATHOLOGIC CONFERENCE
Dr. Loren Golitz (University of Colorado) pre-
sented clinicopathologic cases submitted by mem-
bers of the Society. Drs. Lawrence Eichenfield and
Paul Honig (University of Pennsylvania) reported a
14-year-oid boy with foUicular mucinosis. He had
developed a scaling, annular plaque above the right
eyebrow eight months previously, and hairs were
absent within the involved area. The lesion was un-
responsive to topical antibiotics and hydrocorti-
sone.
FoUicular mucinosis causes grouped, foUicular
papules, nodules, or patches of hair loss. Mycosis
fungoides (MF) occurs in 15% or less of patients but
has never been reported in an individual less than 20
years of age. It was noted that three reports de-
scribed children with foUicular mucinosis who later
developed Hodgkin disease.
Drs. Andrea Dominey, Moise Levy, and H.
Hawkins (Texas Children's Hospital) submitted a
case of congenital neuroblastoma. A newborn had
numerous cutaneous nodules that rapidly increased
in size, as weU as an intraabdomina! mass and he-
patomegaly. Examination of bone marrow and skin
biopsies revealed a round cell tumor consistent with
neuroblastoma. The infant underwent exploratory
laparotomy, at which time a nonresectable retroper-
itoneal tumor was found, with hepatic involvement
but no adrenal gland involvement.
Congenital neuroblastoma is the most common
malignant tumor in neonates and represents 8% to
10% of all cancers in children up to 15 years of age.
In neonates, cutaneous metastases may produce a
"blueberry muffin" appearance. Because one-third
of children have metastases at the time of diagnosis,
the prognosis is poor. Neuroblastoma is the proto-
type of small, round, blue ceU tumors, the others
being rhabdomyosarcoma, Ewing sarcoma, and
non-Hodgkin lymphoma. Marker studies in neuro-
blastoma usually are negative for B and T cells and
fHJsitive for neuron-specific enolase. Dense core
granules (neurosecretory granules) are seen on elec-
tron microscopy. Good prognostic factors include
age less than 1 year, stage I or IV-S tumors, loca-
tion above the diaphragm (not involving adrenal
glands), and well-differentiated morphology (all
markers present). Polyploidy by DNA flow cytom-
etry is associated with a poor prognosis, whereas
aneuploidy is associated with increased survival.
Genomic amplification of the N-myc oncogene is
associated with rapid tumor progression.
Dr. Julie Francis (University of Washington) dis-
cussed a white newborn boy who, after a vacuum
extraction delivery, was noted to have a large ceph-
alohematoma on the left parietal scalp. All scalp
hair was present and no erosions were noted. At 4
days of age, erosions with yellow crusting devel-
oped and continued to enlarge. At 2 months of age,
a raised, flesh-colored plaque developed peripher-
ally around the erosions, and the erosions contin-
ued to heal. At the present time, the plaque mea-
sures 3 X 3 cm with central atrophy, peripheral
flesh-colored papules, crusting, and complete hair
loss within the scarred area. Bacterial and herpes
cultures were negative, as were maternal ANA and
SSA. Examination of skin biopsy specimens
showed fibrosis consistent with scar and a large for-
eign body granuloma reaction to keratin remnants
of hair follicles. Hair foUicles were decreased in
number as well, suggesting a diagnosis of aplasia
cutis congenita. In the discussion. Dr. Wesley Ga-
len (New Orleans) reported that she has seen six
similar cases after vacuum extraction with a defec-
tive machine by the same obstetrician. She thinks
these are secondary to trauma and resulting celluli-
tis, and not to aplasia cutis congenita.
CASES OF THE YEAR
The presentation of cases of the year was organized
by Dr. Samuel Weinberg (New York University).
Drs. Teresita Laude (SUNY-Brooklyn) and Brad
Singman (Staten Island, New York) discussed twin
boys bom at 34 weeks with anhydrotic ectodermal
dysplasia. They had large square foreheads with
bossing, beaked nose, increased scalp vascularity,
and decreased eccrine glands on skin biopsy. Anhy-
drotic ectodermal dysplasia is an X-linked recessive
disorder characterized by anhydrosis, abnormal
dentition, and hypotrichosis.
Dr. Rhonda Schnur (Children's Hospital of Phil-
adelphia) discussed a child with hypohidrotic ecto-
dermal dyspiasia who Ĵiad minima! sweating ability,
hypoplastic nipples, and hypotrophic dentition, and
whose mother had small breasts and abnormal teeth
and nails. Because of recent advances in molecular
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genetics, DNA analysis of linked RFLPs may be a
useful adjunct for genetic counseling in some of the
ectodermal dysplasias.
Dr. Maureen Rogers (The Children's Hospital,
Camperdown, Australia) presented a case of Neth-
erton syndrome in an infant girl who at birth had
erythema and scaling resembling congenital ichthy-
osiform erythroderma. Her hair, including eye-
brows, failed to grow until she was 7 month old, at
which time examination of a hair pluck showed the
typical "ball in a cup" (bamboo hair) picture of
Netherton syndrome. The disorder is autosomal re-
cessive, with skin manifestations most commonly
of ichthyosis linearis circumflexa, and occasionally
of ichthyosiform erythroderma, as in this child.
Atopic dermatitis may be present, and hypema-
tremia has been reported. Because the hair often
does not grow until later, diagnosis is often delayed.
The point was made that if present, an eyebrow hair
can be plucked and the characteristic changes found
there as well.
Dr. Lawrence Eichenfield reported a case of
aplasia cutis congenita (ACC) in association with fe-
tus papyraceous. Fetal death of a twin occurred at
13 weeks, and the mummified fetus was noted at
birth. The viable twin was bom with a scalp lesion
of ACC as weU as linear lesions on the arms and
flank. The disorder in association with fetus papy-
raceous or placental infarct is classified as group V
ACC. One theory of pathogenesis is that embolic or
thromboplastic material is transferred from the
dead fetus through the placenta to the surviving
twin. It is unclear why lesions are symmetric.
Drs. Lynn Williams and Linda Rabinowitz
(Thomas Jefferson University) discussed a case of
tyrosinemia II (Richner-Hanhart syndrome). The
patient was bom at 35 weeks and throughout in-
fancy refused to eat meats. He developed photo-
phobia and tearing at an early age, and at 2 years of
age developed painful plantar keratoderma. The di-
agnosis of tyrosinemia II was made by finding a
high tyrosine level on plasma amino acid screening.
Urinary tyrosine metabolites were also increased.
Tyrosinemia II is due to deficiency of the hepatic
cytosolic enzyme tyrosine aminotransferase. This
patient was treated with avoidance of all dairy prod-
ucts, and showed improvement in the eye and skin
symptoms within two weeks. A low-tyrosine, iow-
phenylalanine diet in infancy is beneficial, and older
children may be maintained on a low-protein diet if
tyrosine levels do not exceed 10 mg/dl.
Dr. Susan MaUory (St. Louis Children's Hospi-
tal) described a newborn with blisters thought to
have HSV and treated with acyclovir. All cultures
and Tzanck preparations were negative, but exami-
nation of a skin biopsy specimen was reported as
"viral Infection." As blistering continued, a repeat
biopsy was performed at age 11 days and inter-
preted as erythema multiforme. Oral prednisone
was begun and the blistering ceased. The pattern of
peripheral blisters around a central buUa ("crown of
jewels") was noted and a skin biopsy specimen was
sent for DIF. Examination revealed linear IgA at
the basement membrane zone. The child was
treated with dapsone and by 6 months of age had
only residual mild scarring of the skin with milia,
but severe eye sequelae and blindness. The two
points to be learned from this case are first, immu-
nobuUous disease can occur in the neonate; and
second, the younger the age at onset of chronic bul-
lous disease of childhood, the more significant the
sequelae tend to be.
Dr. Allison Holm (Batavia, New York) presented
a case of rash with Epstein-Barr virus (EBV) infec-
tion and amoxicillin therapy. An 8-year-old boy de-
veloped fever, lymphadenopathy, hepatomegaly,
and jaundice. He had been treated with amoxiciUin
two weeks earlier and developed a diffuse morbiUi-
form eruption. The mono spot test was negative,
and a broad differential diagnosis was considered,
including Kawasaki disease and leptospirosis. The
child was suspected of having virus-associated he-
mophagocytic syndrome or X-linked lymphoprolif-
erative syndrome; however, he recovered with VP-
16 and intravenous gammaglobuiin. It is important
to remember that in childhood mononucleosis, the
mono spot test is frequently negative and EBV-
specific serologies must be obtained.
Tuesday, July 2, 1991
RESEARCH AWARD
The Resident/Fellow Pediatric Dermatology Re-
search Award was presented to Steven Shpall,
M.D. (University of California, San Francisco) for
his study, "The Risk of Melanoma in Black Pa-
tients." He found that the number of blacks with at
least one congenital nevocytic nevus (CNN) was
1.8%. Malignant transformation was strongly age
dependent. For those under 15 years old, the risk
was 1 in 10,000 (0.01%), and for the group age 15 to
35 years it was I in 3700 (0.027%). The overall risk
was 0.61%. These data assume that all melanomas
arise in CNN and, therefore, may overestimate the
risk by 10- to 100-fold. Dr. Shpall concluded that
removal of CNN is not recommended in black pa-
tients, especially those under age 35.
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CASES IN SEARCH OF A DIAGNOSIS
Dr. William Weston (University of Colorado) pre-
sented four "Cases in Search of a Diagnosis." The
first, from Dr. Maureen Rogers, was a 6-year-old
with unusual annular erythema beginning at 1 hour
of age and consisting of intensely pruritic rings
within rings, largely on the trunk. The child's gen-
eral health has been unaffected. Results of exhaus-
tive laboratory studies were unremarkable; a biopsy
specimen showed an infiltrate with a predominance
of eosinophils and neutrophils, with distinct flame
figures as seen in Well syndrome. Spirochetes
present on one specimen stained with Warthin-
Starry could not be found in subsequent specimens.
The long list of treatments that failed included pred-
nisone, cromolyn, antihistamines, antibiotics, dap-
sone, phototherapy, and elimination diet. Members
of the audience mentioned three separate cases with
similar lesions. These children went on to have se-
vere liver and renal disease, but no diagnosis. Be-
cause the lesions in Dr. Rogers' patient cleared only
with fever, the use of alpha-interferon was sug-
gested.
Dr. Elaine Siegfried (University of Iowa) dis-
cussed an unusual port-wine stain present at birth
with extensive localized loss of subcutaneous fat.
Biopsy was unremarkable. Diagnosis of atypical cu-
tis marmorata telangiectatica congenita or atypical
lipodystrophy was proposed. Dr. Anne Lucky
noted that in similar cases, the atrophic component
gradually resolved without treatment.
A second case from Dr. Siegfried was that of a
child with acquired erythema of one cheek after a
four-day febrile illness. Biopsy showed an exuber-
ant lichenoid infiltrate extending deeply into fat. On
direct immunofiuorescence, there was granular IgM
at the basement membrane zone. Remarkable labo-
ratory study results included erythrocyte sedimen-
tation rate 72, platelets 607,000, and negative ANA
and Ro antibodies. Numerous treatments from top-
ical steroids to laser yielded nothing. Audience
members suggested Jessner benign lymphocytic in-
filtrate, foreign body reaction (e.g., fiberglass), con-
nective tissue disease, and panniculitis as possible
diagnoses.
For the last case. Dr. Amy Paller (Northwestern
University) asked, "What's this syndrome?" Bom
prematurely, the child had microcephaly, unusual
facies, abnormal tooth enamel, mental retardation,
absence of the corpus callosum, retinitis pigmento-
sa, strabismus, deafness, renal fsdlure, and hyper-
tension. Cutaneous findings included facial erythe-
ma (increased with heat), eczema, unilateral cafe au
lait macuies, and one axillary freckle. The famUy
history was unremarkable, and results of chromo-
some studies were normal. The consensus of the au-
dience was that this most likely represented a chro-
mosomal abnormality not yet identified by gene
mapping.
ATOPIC DERMATITIS
ln her lecture on atopic dermatitis. Dr. Rona
MacKie focused on European research and experi-
ence. She cited a 1989 study by Cookson at Oxford
that linked IgE to chromosome llq, and showed
that specific allergic responses are linked to the ma-
jor histocompatibility complex. The abnormal regu-
lation and overproduction of IgE is secondary to a
preferential expansion of a subset of T helper cells
with a relative reduction of gamma-interferon-
producing T helper cells. Basic research has shown
that the mononuclear cells in atopic patients are
defective in controlling production of interleukin
(IL)-4. A high level of IgE is the result of IL-4 over-
production. Thus, in atopic dermatitis the cytokine-
mediated immune response is distorted.
In studies of dust mite aUergy Dutch researchers
have shown the likely role for aUergen-specific T
helper response. The importance of Langerhans
ceUs in trapping igE-antigen complexes and antigen
presentation was stressed.
Dr. MacKie reviewed several treatment modali-
ties for atopic dermatitis. Work in her own labora-
tory has centered on the role of Staphylococcus au-
reus in initiating and perpetuating atopic dermatitis
lesions. Although other microorganisms are not sig-
nificant, the number of S. aureus organisms (espe-
cially phage type III) have a quantitative relation-
ship to disease activity. Based on these
observations, studies of topical mupiricin were the
next step and yielded highly statistically significant
reduction in S. aureus colonization and significant
clinical improvement.
Unpublished information on the use of Chinese
herbal medicine included a study of 47 children,
which showed improvement in 51% of atopies with
no effect on asthma or IgE levels. Until analysis of
the herbs is completed, concern over the safety of
this therapy remains. Finally, Dr. MacKie dis-
cussed the striking clinical improvement noted with
subcutaneously injected gamma-interferon. It is hy-
pothesized that gamma-interferon controls IgE pro-
duction by its action on mononuclear cells.
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SCLERODERMA AND MORPHEA
Dr. Jouni Uitto (Thomas Jefferson University) dis-
cussed scleroderma and morphea in children. He
reported that at least 14 different coUagens are clas-
sified and that five new geneticaUy distinct ones
have recently been discovered, all with alpha
chains. In reviewing fibrotic diseases. Dr. Uitto
stressed that the common pathway and haUmark of
these conditions are connective tissue deposition
and primary collagen accumulation, respectively.
In his research using abundantly available tissue
of keloid scars as a model. Dr. Uitto has shown that
mRNA of types I and IV coUagen is increased.
Transforming growth factor-beta increases coUagen
deposition. Its origin is probably vascular, either
from platelets or endothelial cells.
Turning to treatment. Dr. Uitto discussed several
drugs. PeniciUamine is believed to prevent intramo-
lecular cross-linking. It is effective in progressive
systemic sclerosis and linear morphea, but takes six
to eight months to work and must be started early in
the disease course. Side effects are abundant. Cor-
ticosteroids probably act by increasing coUagenase
activity and reducing cross-linking. Although their
systemic use has been disappointing, topical ste-
roids are useful in softening lesions. Gamma-
interferon antagonizes transforming growth factor-
beta activity. Preliminary data indicate that it may
be useful. In anecdotal reports, phenytoin improved
linear morphea, but Dr. Uitto is not impressed with
its effectiveness. In the United States, penicillin is
administered only to patients with increased Borre-
lia titers, but in Europe all patients with morphea or
systemic sclerosis are treated with high dosages.
Photopheresis may be worth a try in rapidly pro-
gressive SS but studies to date have not been con-
vincing.
IMAGING NEUROCUTANEOUS SYNDROMES
Dr. Rich Towbin (Pittsburgh Children's Hospital)
spoke on imaging studies in neurocutaneous syn-
dromes. In deciding whether to use computerized
tomography (CT) or magnetic resonance imaging
(MRI), he stressed that CT is stilt an excellent
method and costs one-third of what MRI does. The
latter is particularly useful for posterior fossa le-
sions, craniocervical junction, leukoencephalopa-
thy, temporal lobe lesions, and spinal cord lesions.
However, it is somewhat problematic in children
due to the extended time required and the confining
nature of the equipment.
Controversy remains over the desirability of
baseline studies in neurofibromatosis type 1 (NF-1).
TraditionaUy, CT has been weak, whereas MRI
finds "too much." Unidentified bright objects pose
a dilemma for the radiologist. These probably rep-
resent hamartomas in most cases and, in general,
require intervention only if there is a mass effect. In
NF-2 MRI is definitely superior to CT, and very im-
portant in identifying tumors of the eighth nerve. In
diagnosing tuberous sclerosis, CT is a good tool for
identifying cerebral calcification; MRI is helpful in
detecting malignant transformation. In addition, CT
is the best method for detecting the characteristic
serpiginous train-track calcifications of Sturge-
Weber syndrome. For the classic hemangioblas-
toma of von Hippel-Lindau, angiography has been
replaced by MRI.
VASCULITIC DISEASES
Vasculitic diseases of childhood were addressed by
Dr. Thomas Lehman (Cornell University). In his
broad overview he stressed that many specialists
may be required to diagnose and care for these chil-
dren, who may not fit into any neat category. Key
points included the fact that children with linear
scleroderma en coup de sabre may have vasculitis
in the underlying brain. Also, en coup de sabre may
be easily confused with Parry-Romberg syndrome
(progressive facial hemiatrophy). The latter is dis-
tinguished by tongue involvement.
In summation. Dr. Lehman gave the foUowing
take home messages: (!) disease expression is a di-
rect consequence of the size of the vessel involved;
(2) each vessel type has its own characteristics with
regard to pressure, flow, cellular makeup, and ana-
tomic distribution; and (3) disease manifestations
are influenced by the size (and several other char-
acteristics) of the antigen or inciting agent, and the
host's genetic makeup.
NEUROFIBROMATOSIS
In the first of two lectures. Dr. Vincent Riccardi
(Alfigen, Pasadena, California) gave a fascinating
review of new developments and important charac-
teristics of neurofibromatosis (NF). Based on his
observations of hundreds of patients, he had many
clinical pearls. The macromelanosomes of cafe au
lait macules (CALM) are not helpful in diagnosis
due to their presence in healthy subjects and the
great difficulty in identifying them in children and
all black patients. He maintains that there is no rea-
son to biopsy patients to make the diagnosis of NF.
Axillary freckling, which occurs early in NF, must
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be a cluster of at least 10 or 12 to be diagnostic.
Acquired freckling in NF is a different phenome-
non, occurring in areas of friction (e.g., neck, axil-
lae) due to environmental factors, not genetics.
The macules are highly variable: they may be
two-tone or spotted, ragged or smooth in outline, of
huge size, and darken with sun exposure. In gen-
eral, the darker the background skin, the darker the
CALM. The "Riccardi sign" is the presence of an
abnormal hair whorl overlying the spine in NF-1,
indicating the presence of either vertebral dysplasia
or plexiform neurofibroma underneath. This finding
is significant because it shows that NF-1 is a defect
with onset in embryonic development. The pres-
ence of juvenile xanthogranuloma is an important
sign of NF-1 in young children, present in up to 1%.
This lesion may lead the child to the dermatologist,
with eventual discovery of NF. Another important
association is chronic myeiogenous leukemia, seen
in 0.5% of children with NF. Dr. Riccardi believes
that almost all children with NF-1 can be diagnosed
on clinical grounds by age 1. Infants with CALM
should simply be followed closely and considered
as having presumptive NF-1 until proved other-
wise.
CLINICOPATHOLOGIC CONFERENCE
Concluding the day's program. Dr. Loren Golitz
presented the CPC with cases of blue rubber bleb
syndrome. Sweet syndrome, and non-X histiocyto-
sis.
Wedn«sday, July 3, 1991
CONTROVERSIES IN
PEDIATRIC DERMATOLOGY
Dr. Alvin Jacobs (Stanford University) reviewed
the epidemiology, natural history, clinical features,
and treatment of hemangiomas. With many superb
illustrations from his own practice, he demon-
strated the complete regression of many untreated
lesions. He cautioned those who embark on new
therapies to remember the dictum of primum non
nocere. When he sees an infant whose hemangioma
will spontaneously regress without treatment, he
spends additional time reassuring the parents by
showing them examples of others that involuted
spontaneously. He photographs the infant's heman-
gioma and schedules frequent follow-up visits to il-
lustrate to the parents the progress of the lesion.
Dr. Karen Rothman (Westboro, Massachusetts)
discussed the experimental use of the pulsed-dye la-
ser for treatment of hemangiomas. She emphasized
the need for controUed studies to determine the ef-
ficacy and safety of this treatment. She outlined the




Dr. Virginia Sybert (University of Washington) out-
lined an approach to the ectodermal dysplasias.
These are defined as disorders in which there are
two or more abnormalities in ectodermal deriva-
tives: hair, teeth, nails, sebaceous glands, sweat
and mucous glands, and lens and conjunctiva of the
eye. One system of classification used by Freire-
Maia and Pinheiro in their textbook Ectodermal
Dysplasia numbers the ectodermal structures: 1,
trichodystrophy; 2, dental defects; 3, onychodys-
trophy; 4, dyshidrosis; and 5, other abnormalities.
Hypohidrotic ectodermal dysplasia (Christ-
Siemens-Touraine syndrome) was reviewed. It is an
X-linked recessive disorder. The mutation is lo-
cated on the proximal portion of the long arm of the
X chromosome. It affects approximately 1 in
100,000 males bom. Affected individuals have
sparse to absent scalp and vellus body hair, hy-
podontia or adontia. a paucity of sweat glands, and
decreased mucus production in the respiratory tree.
Although previously referred to as anhidrotic, pa-
tients have some ability to sweat. The nails are nor-
mal. Patients may suffer from eczema, frequent up-
per respiratory tract infections, and difficulty
lacrimating. They have characteristic facies with a
saddle nose, midfacial hypoplasia, and periorbital
hyperpigmentation. The diagnosis in newboms may
be difficult to make if there has been no prior family
history. One clue is the presence of peeling skin that
may be mistaken for a coUodion membrane. If the
diagnosis is missed at birth, the infant often experi-
ences bouts of unexplained fever due to inability to
sweat. A dental panoramic x-ray demonstrates the
absent primary teeth and peg-shaped incisors. By
puberty many patients develop some ability to
sweat and also acquire secondary sexual hair. In
their management, it is important to have them fit-
ted for dentures by 3 to 5 years of age.
Other forms of ectodermal dysplasia include the
Clouston syndrome, which is known as the hidrotic
form. It is an autosomal dominant disorder charac-
terized by normal sweating and normal teeth, but
abnormal nails, hair, Eind mucous glands. Rapp-
Hodgkin ectodermal dysplasia is an autosomal
dominant condition with hypotrichosis, hypohidro-
sis, onychodystrophy, and cleft lip and palate.
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Ankyloblepharon-ectodermal dysplasia-cleft lip and
palate (AEC) and ectrodactyly-ectodermal dysplasia-
cleft lip and palate (EEC) are two other autosomal
dominant conditions. The former may develop pyo-
genic granuloma-like lesions in the scalp.
Information for patients and their physicians is
available from the National Foundation for Ecto-




Dr. Jouni Uitto reviewed the biochemistry of the
coUagen molecule. Functional alterations in colla-
gen affect the cornea, tendon, cortical bones, carti-
lage, lungs, and liver. Molecular defects in collagen
molecules give rise to the various clinical pheno-
types of Ehlers-Danlos disease (ED). The 11 dis-
tinct forms show a wide spectrum of involvement,
although some overlap is seen among them. Clini-
cally, ED is characterized by loose-jointedness, hy-
perextensible skin, and eye problems including stra-
bismus and fragile comeas. The inheritance in the
various forms of ED may be autosomal dominant,
autosomal recessive, or X-linked recessive. Fifty
percent of patients cannot be easUy classified into a
specific type. The prevalence of these disorders de-
pends on the sensitivity of the diagnostic criteria.
Types IV, VI, VII, IX have been characterized
biochemically as coUagen defects. Type IV ED is
due to a deficiency of type 3 collagen, which is
abundant in skin and vascular connective tissue.
This explains the increased frequency of major gas-
trointestinal or aortic rupture in these patients. It is
important to establish an accurate diagnosis. This
can be done by analyzing the coUagen in a skin bi-
opsy specimen.
Type VI ED is an autosomal recessive disorder
characterized by scleral fragility leading to blind-
ness, marked hyperextensible skin, and musculo-
skeletal deformities. It is due to a deficiency of lysyl
hydroxylase. This can be confirmed by measuring
hydroxylysine in a skin biopsy specimen. Some pa-
tients have altered ability to use the cofactor ascor-
bic acid. The deficiency can be overcome by treat-
ment with high amounts of ascorbic acid in the
range of 2 to 4 g/day.
Typie VII Ehlers-Danlos is characterized by de-
fective conversion of the precursor molecule
procoU£igen to a mature product.
Type IX disease is caused by a deficiency in ly-
syloxid£^e. The primary defect is the altered coppei
metabolism, since copper is a cofactor for the en-
zyme. Diagnosis is made by measuring copper lev-
els.
Abnormalities of elastic fibers were reviewed.
Elastic fibers are a minor constituent of normal
skin, making up 2% to 4% of the extracellular ma-
trix. They are composed of two components: elas-
tin, an amorphous-appearing protein, and a distinct
microfibrillar protein. The gene for elastin is on a
chromosome that was recently cloned. It is very
complex and susceptible to deletions. Elastin un-
dergoes posttranslational modification by cross-
linking of molecules mediated by lysyioxidase, a
copper-dependent enzyme.
Heritable diseases in which elastic structures are
structurally abnormal include pseudoxanthoma
elasticum, Buschke-Ollendorff syndrome, cutis
laxa, alpha|-antitrypsin deficiency, Ehlers-Danlos
type IX, Menkes syndrome, and Marfan syndrome.
In alphaj-antitrypsin deficiency there is a deficiency
in the inhibitor of elastase. Elastic structures are de-
stroyed in the lung. Both Menkes syndrome and
type IX ED show low copper levels but have signif-
icantly different outcomes. An abnormal mi-
crofibrillar component of the elastic fiber recently
was shown in Marfan syndrome.
Cutis laxa, characterized by loose skin, with
variable inheritance can also be an acquired condi-
tion, as seen in severe drug eruption or sun damage.
Skin biopsy specimens show a loss of elastin. The
mechanism of the inherited disorder is unknown.
Possibilities include reduced synthesis, nonfunc-





Dr. Rich Towbin chronicled the advances in radio-
logic imaging and in biosynthetic material that have
created a new role for embolotherapy. Patients with
vascular malformations that include arteriovenous
malformations and fistulas, who are symptomati-
caUy at risk, can be offered treatment that may
achieve palliation. The biosynthetic materials in-
clude poly vinyl alcohol (Ivelon), dehydrated alco-
hol, gel foam, and glues. Several types of coils for
occlusion can be introduced by variable-stiffness
microcatheters that are soft and spaghetti-Hke.
These procedures are mostly used in vascular mal-
formations of the head and neck. In their prese-
lected group of patients they successfully obtained
palliation in all and cures (five yrs without recur-
rence) in 25%. The other area of use is in vascular
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tumors pdor to surgery to control blood loss. These
procedures are not without complications, such as
stroke, facial weakness, pain, and revasculariza-
tion.
BIOLOGIC BASE OF ICHTHYOSIS
Dr. Joseph McGuire (Stanford University) re-
viewed the events in terminal differentiation of the
epidermis. It has been known for some time that
ceU division is accelerated in some forms of ichthy-
osis. Although much effort has been expended in
studying the synthesis of keratin, it does not appear
to piay much of a role in the ichthyoses. Filaggrin is
an important molecule that probably is involved in
ichthyosis vulgaris and the retention of scale. In one
theory, as the keratinocyte matures it loses or-
ganelles. The filaggrin (stratum corneum basic pro-
tein) disease is included. Little is known of the basic
abnormalities in the most common ichthyoses such
as ichthyosis vulgaris.
Lamellar ichthyosis, which often is manifested as
a collodion baby, is a heterogeneous group that has
also remained an enigma. On the other hand,
X-linked ichthyosis provided the major break-
through for experimental biologists with the discov-
ery of the steroid sulfatase deficiency in this disor-
der. The scale of patients with X-linked ichthyosis
contains increased cholesterol sulfate that has been
circumstantially linked to the delay in cell separa-
tion. Other lipid disorders have been associated
with ichthyosis. Another exciting discovery has
been the identification of a defect in fatty alcohol
oxidoreductase in Sjogren-Larsson syndrome, an
autosomal recessive condition with ichthyosis,
spastic quadriplegia, seizures, mental retardation,
and glistening retinal spots. Patients improve when
they receive medium-chain lipids. Dorfman de-
scribed a disorder of neutral lipid storage associated
with ichthyosis, myopathy, neurosensory deafness,
cataracts, and a fatty liver. Refsum syndrome in-
cludes ichthyosis, cerebeUar ataxia, and retinitis
pigmentosa. lt is due to a deficiency of phytanic
acid oxidase. If dietary phytanic acid is restricted,
the ichthyosis improves.
NEUROFIBROMATOSIS IN CHILDHOOD
Dr. Vincent Riccardi continued his review of the
clinical manifestation of neurofibromatosis by dis-
cussing some of the peculiarities in the location of
neurofibromas. The lesions have a proclivity to de-
velop on the areolae and nipples of 90% of adult
women with neurofibromatosis and 10% of males.
He feels that this is not necessarily due to an estro-
gen effect, but may have something to do with the
presence of erectile tissue or highly vascular tissue.
Neurofibromas are rarely seen over the shins, glans
penis, and upper Up. This may be due to lack of fat
in these areas and the associated change in temper-
ature. Another peculiarity of location was demon-
strated in a patient with extensive neurofibromas
who had no lesions in an area of motor and sensory
deficit. The last example was a patient who devel-
oped numerous lesions in the area of a donor site for
a skin graft.
Patients with NF-2 have findings that may mimic
other disorders. They do not all have cafe au lait
macules. If skin tumors are present, they are
schwannomas and may have overlying hyperpig-
mentation and hypertrichosis. Four cases of NF-2
have been discovered in patients who had nasola-
bial neurofibromas. This appears to be an important
pathognomonic sign. Patients should be cautioned
to avoid swimming or diving alone since they are at
risk of becoming disoriented under water from the
vestibular schwannomas.
Dr. Riccardi briefly discussed his management of
children with neurofibromatosis and outlined a
yearly screen that includes cranial imaging in the
asymptomatic patient. He admitted that this was
controversial.
The molecular biology of the disease was dis-
cussed. The genes for NF-1 and NF-2 have been lo-
calized to the long arm of chromosomes 17 and 22,
respectively. The NF-1 gene has been cloned. It is a
large gene with 300,000 KB. In a study of 300 pa-
tients with NF-1 the exact mutation was recognized
in only 3%. Buried in the NF gene are three other
genes. Two of them are known as EVIS (equotropic
viral insertion site) and are associated with murine
chronic myeiogenous leukemia (CML). This may be
important since 0.5% of patients with NF develop
CML. Another gene buried within the NF gene is
the OMGP (oligodendrocyte myelin glycoprotein).
Some patients with NF-1 develop a poly neuropathy
that might relate to aberrant expression of this bur-
ied gene. In addition, the NF-1 gene is an activating
protein for guanosine triphosphatase, affecting
growth control through RAS and with a number of
other oncogenes. The NF-2 gene is probably a
tumor-suppressor gene. Dr. Riccardi speculated
that the target area of this mutant gene may be the
secretory processes of the intemal cell membranes.
Evidence for this may be found in the giant melano-
somes of neurofibromatosis arising from the Golgi
apparatus and the endoplasmic reticulum.
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ALOPECIA AREATA IN CHILDHOOD
Dr. Eleanor Sahn (Medical University of South
CaroUna) reviewed the clinical manifestations of
alopecia areata in childhood. She cited a frequency
of 17 cases per 1,000,000, with 63% having onset
before age 20. Five percent of patients advance to
alopecia totalis and 1% to alopecia universalis. She
discussed the heredity, with a positive family his-
tory in up to 27% of patients, the association with
atopy in 18% of children, and the 5% association of
autoimmune disorders such as vitiligo and thyroid
disease in alopecia areata. The various theories of
pathogenesis include infection, neurologic factors,
vascular changes, and immune dysfunction. Im-
mune dysfunctions that have been cited are the
presence of autoantibodies, decreased T cell
counts, anergy, and decreased mitogen response.
Therapy was reviewed, such as corticosteroids
(topical, intralesional, systemic), anthraUn, topical
immunotherapy with diphencyprone, PUVA, cy-
closporin, thymopentin, minoxidil, inosoplex,
isotretinoin, and the use of wigs and psychologic
support. The address of the National Alopecia
Areata Foundation is 714 C Street, Suite 216, San
Raphael, CA 94901; telephone (415) 456-4644.
CASES OF THE YEAR
Dr. Uona Frieden (University of California, San
Francisco) reported a newborn with macrocephaly
who on day 6 of life developed macular erythema
over the left side of the face. A CT examination
showed hydrocephalus consistent with a Dandy-
Wtdker cyst. At 5 weeks of age the vascular lesion
had developed Into an ulcerated hemangioma that
required systemic steroids. An additional finding
was a choroidal angioma of the eye. A review of the
literature revealed 18 other cases of facial hemangi-
omas, abnormalities of the posterior fossa, and ab-
normal eye findings.
Dr. Bemard Cohen (Johns Hopkins University)
described a child with blue rubber bleb nevus syn-
drome who had repeated episodes of acute anemia
requiring several transfusions. The anemia was not
due to gastrointestinal blood loss but seemed to be
due to a hemolytic anemia with a localized dissem-
inated intravascular coagulation.
Dr. Steven Resnick (University of North Caro-
lina) described a newbom who had a large, tense
nodule on the buttock thought to be a hemangioma.
When it began to hemorrhage, it was excised. The
pathology revealed a spindle cell neoplasm with
small, spindle-shaped, vascular spaces. There have
been two different interpretations: neurogenic sar-
coma and congenital fibrosarcoma.
Dr. Andrea Dominey reported two infants with
congenital self-healing reticulohistiocytosis
(Hashimoto-Pritzker disease). They had ulcerated
lesions appearing at birth, resolving spontaneously
over several months. Their skin biopsy specimens
were typical, with histiocytic infiltrates surrounded
by reticulum fibers. Electron microscopy revealed
Birbeck granules and laminated dense bodies.
Dr. Robert Silverman (Annandale, Virginia) dis-
cussed a 29-year-old man with Down syndrome
who had generalized syringomas that became more
prominent with anxiety or activity. He cited an ear-
lier study that found syringomas in 18% of those
with Down syndrome.
Dr. Karen Wiss (Boston Children's Hospital) de-
scribed a 5-month-old who was born with yellowish
red plaques and nodules involving the nose, fore-
head, and cheeks, spreading to the extremities. Le-
sions over the extremities were covered with an in-
creased density of hair. Except for hoarseness and
nasal stuffiness the child was well. Laboratory stud-
ies showed only an elevated sedimentation rate and
a mild microcytic anemia. Ear, nose, and throat ex-
amination revealed an enlarged uvula. The family
history was significant in that the patient's father,
brother, paternal aunt, and cousin had similar le-
sions at birth that resolved spontaneously. Only a
paternal uncle has persistent lesions. He has a diag-
nosis of sarcoidosis. A skin biopsy specimen from
the patient revealed sheets and nodular aggregates
of histiocytoid cells. Macrophage markers were
markedly positive, and Langerhans ceU markers
were focally positive. Electron microscopy showed
no true Birbeck granules. Invaginations of the
plasma membrane appeared to represent incom-
pletely formed Birbeck granules. The whole picture
was interpreted as an indeterminate ceU prolifera-
tion. Because of progressive deformity of the skin,
the child was treated with topical steroids, topical
nitrogen mustard, and vinblastine, with no re-
sponse.
Maira Alvarez-Franco (Children's Memorial
Hospital, Chicago) discussed a Fusarium infection
in an 18-year-old leukemic that caused oral lesions
and a lip ulceration. Within several days a general-
ized rash developed. A biopsy specimen showed
fungal hyphae and cultures grew Fusarium. The pa-
tient died despite treatment with amphotericin.

